Breaking News

Discovery Life Sciences to Acquire Gentest Business from Corning

Biospecimen leader to create leading in vitro drug metabolism services offering.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Discovery Life Sciences, the biospecimen and biomarker specialists, has acquired the Gentest business unit, part of Corning Incorporated’s life sciences business. The acquisition of Gentest complements Discovery’s recent acquisition of In Vitro ADMET Laboratories (IVAL) in December of last year and establishes Discovery as a leading provider of in vitro drug experimental systems to the pharmaceutical and life sciences industry. The Gentest portfolio includes absorption and transpo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters